Tier 3 · Filer Universe

Keros Therapeutics, Inc.

KROS · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$11.32
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001664710
Liquidity rank
#4108
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$244.06M2025-12-310001664710-26-000018
Annual diluted EPS2.32025-12-310001664710-26-000018
Quarterly revenue$0.002026-06-300001664710-26-000049
Quarterly diluted EPS-1.452026-06-300001664710-26-000049

SEC EDGAR Frames batch generated 2026-09-08T00:39:23.524Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames